Michel Heenen

769 total citations
39 papers, 524 citations indexed

About

Michel Heenen is a scholar working on Oncology, Molecular Biology and Dermatology. According to data from OpenAlex, Michel Heenen has authored 39 papers receiving a total of 524 indexed citations (citations by other indexed papers that have themselves been cited), including 12 papers in Oncology, 11 papers in Molecular Biology and 10 papers in Dermatology. Recurrent topics in Michel Heenen's work include Viral-associated cancers and disorders (7 papers), Histiocytic Disorders and Treatments (4 papers) and Melanoma and MAPK Pathways (4 papers). Michel Heenen is often cited by papers focused on Viral-associated cancers and disorders (7 papers), Histiocytic Disorders and Treatments (4 papers) and Melanoma and MAPK Pathways (4 papers). Michel Heenen collaborates with scholars based in Belgium, France and Poland. Michel Heenen's co-authors include Jean‐Paul Van Vooren, Dominique Parent, Jean‐Christophe Noël, Philippe M. Vereecken, Thierry Simonart, Philippe Hermans, Johan R. Boelaert, Marianne Laporte, Robert Snoeck and Graciela Andreï and has published in prestigious journals such as International Journal of Cancer, Journal of Investigative Dermatology and Journal of the American Academy of Dermatology.

In The Last Decade

Michel Heenen

37 papers receiving 504 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Michel Heenen Belgium	14	180	176	165	81	77	39	524
Junji Tsuruta Japan	13	205 1.1×	159 0.9×	195 1.2×	45 0.6×	39 0.5×	34	613
Ángel Vera Spain	11	62 0.3×	242 1.4×	183 1.1×	68 0.8×	108 1.4×	20	473
J Palou Spain	13	133 0.7×	117 0.7×	61 0.4×	132 1.6×	164 2.1×	32	456
Toshiyuki Kitoh Japan	16	249 1.4×	246 1.4×	199 1.2×	43 0.5×	25 0.3×	41	809
Manuel Almagro Spain	13	76 0.4×	61 0.3×	73 0.4×	119 1.5×	134 1.7×	49	473
Razieh Soltani‐Arabshahi Iran	13	80 0.4×	75 0.4×	303 1.8×	99 1.2×	261 3.4×	19	679
Thomas M. Yankee United States	16	126 0.7×	233 1.3×	486 2.9×	48 0.6×	33 0.4×	35	897
Jesse L. Gurgel United States	5	176 1.0×	97 0.6×	429 2.6×	68 0.8×	87 1.1×	6	700
Joerg C. Prinz Germany	12	65 0.4×	104 0.6×	342 2.1×	49 0.6×	204 2.6×	15	584
Yuttana Srinoulprasert Thailand	13	125 0.7×	51 0.3×	124 0.8×	60 0.7×	122 1.6×	33	562

Countries citing papers authored by Michel Heenen

Since Specialization

Citations

This map shows the geographic impact of Michel Heenen's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Michel Heenen with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Michel Heenen more than expected).

Fields of papers citing papers by Michel Heenen

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Michel Heenen. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Michel Heenen. The network helps show where Michel Heenen may publish in the future.

Co-authorship network of co-authors of Michel Heenen

This figure shows the co-authorship network connecting the top 25 collaborators of Michel Heenen. A scholar is included among the top collaborators of Michel Heenen based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Michel Heenen. Michel Heenen is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Vereecken, Philippe M., Ahmad Awada, Stefan Suciu, et al.. (2009). Evaluation of the prognostic significance of serum galectin-3 in American Joint Committee on Cancer stage III and stage IV melanoma patients. Melanoma Research. 19(5). 316–320. 45 indexed citations

Ezzedine, Khaled, et al.. (2008). Concomitant Xeroderma pigmentosum and disseminated small plaque psoriasis: first case of an antinomic association. Cases Journal. 1(1). 74–74. 2 indexed citations

Vereecken, Philippe M., et al.. (2006). La stratégie de prévention et de dépistage du mélanome cutané. Dépôt institutionnel de l'Université libre de Bruxelles (Université Libre de Bruxelles). 27(4). 1 indexed citations

Ezzedine, Khaled, et al.. (2006). Onchocerciasis‐Associated Limb Swelling in a Traveler Returning from Cameroon. Journal of Travel Medicine. 13(1). 50–53. 11 indexed citations

Heenen, Michel, et al.. (2004). Interferon Alpha as Adjuvant Postsurgical Treatment of Melanoma: A Meta-Analysis. Dermatology. 208(1). 43–48. 27 indexed citations

Heenen, Michel. (2003). [Psoriasis: pathogenesis and treatment].. PubMed. 24(3). 139–47. 5 indexed citations

Simonart, Thierry, Johan R. Boelaert, Graciela Andreï, et al.. (2002). Desferrioxamine enhances aids‐associated Kaposi's sarcoma tumor development in a xenograft model. International Journal of Cancer. 100(2). 140–143. 13 indexed citations

Simonart, Thierry, Michel Heenen, Chantal Degraef, et al.. (2000). Iron Chelators Inhibit the Growth and Induce the Apoptosis of Kaposi's Sarcoma Cells and of their Putative Endothelial Precursors. Journal of Investigative Dermatology. 115(5). 893–900. 76 indexed citations

Degraef, Chantal, Jean‐Christophe Noël, Dominique Fokan, et al.. (1998). Overexpression of Bcl-2 in Kaposi's Sarcoma-Derived Cells. Journal of Investigative Dermatology. 111(3). 349–353. 23 indexed citations

10.

Simonart, Thierry, Jean‐Christophe Noël, Graciela Andreï, et al.. (1998). Iron as a potential co‐factor in the pathogenesis of Kaposi's sarcoma?. International Journal of Cancer. 78(6). 720–726. 10 indexed citations

11.

Simonart, Thierry, Jean‐Christophe Noël, Graciela Andreï, et al.. (1998). Iron as a potential co-factor in the pathogenesis of Kaposi's sarcoma?. International Journal of Cancer. 78(6). 720–726. 39 indexed citations

12.

Heenen, Michel, et al.. (1996). Angiokeratoma corporis diffusum with normal enzyme activities. European Journal of Dermatology. 6(5). 359–361.

13.

Heenen, Michel, et al.. (1995). Pharmacological action of lithium in the pathogenesis of psoriasis. European Journal of Dermatology. 5(5). 413–415. 6 indexed citations

14.

Lowy, M., et al.. (1994). Melanoma in an albino patient. European Journal of Dermatology. 4(5). 365–367. 1 indexed citations

15.

Dobbeleer, G. De, et al.. (1993). Morphea after beta-blocker therapy. European Journal of Dermatology. 3(2). 108–109. 6 indexed citations

16.

Dobbeleer, G. De, et al.. (1992). In vitro acantholysis induced by D‐penicillamine, captopril, and piroxicam on dead de‐epidermized dermis. Journal of Cutaneous Pathology. 19(3). 181–186. 8 indexed citations

17.

Parent, Dominique, et al.. (1990). Spreading of Psoriatic Plaques: Alteration of Epidermal Differentiation Precedes Capillary Leakiness and Anomalies in Vascular Morphology. Journal of Investigative Dermatology. 95(3). 333–340. 46 indexed citations

18.

Dobbeleer, G. De, et al.. (1989). Topical antibiotic treatment of primary and secondary skin infections with mupirocin. Dépôt institutionnel de l'Université libre de Bruxelles (Université Libre de Bruxelles). 15(1). 59–63. 1 indexed citations

19.

Parent, Dominique, et al.. (1985). Arthrite à Fusarium chez un patient burundais. Dépôt institutionnel de l'Université libre de Bruxelles (Université Libre de Bruxelles). 14(2). 201–204. 3 indexed citations

20.

Heenen, Michel, et al.. (1973). Nuclear binding of tritiated actinomycin in basal cell carcinoma and in normal human epidermis.. PubMed. 33(11). 2624–6. 5 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact